Posts by: Iqra Mumal, MSc

Iqra Mumal, MSc

Iqra holds a MSc in Cellular and Molecular Medicine from the University of Ottawa in Ottawa, Canada. She also holds a BSc in Life Sciences from Queen’s University in Kingston, Canada. Currently, she is completing a PhD in Laboratory Medicine and Pathobiology from the University of Toronto in Toronto, Canada. Her research has ranged from across various disease areas including Alzheimer’s disease, myelodysplastic syndrome, bleeding disorders and rare pediatric brain tumors.

May 9, 2019

Sunlight Exposure Reduces Risk of Non-Hodgkin’s Lymphoma, Study Finds

News

People with high exposure to sunlight or ultraviolet radiation are significantly less likely to develop non-Hodgkin’s lymphoma compared to those with low exposure, but vitamin D levels in the body ... Read more

April 30, 2019

Chemotherapy Improves Survival of AIDS-related Lymphoma Patients, Study Finds

News

Patients with AIDS-related lymphoma have better survival outcomes when standard chemotherapy is added to their combined antiretroviral therapy (cART), a new study shows. The study, “The clinical features and prognosis ... Read more

April 26, 2019

CAR T Cells Can Directly Target Lymphoma in Mice, Study Finds

News

Using an advanced microscopic technique to visualize how CAR T cells work in a mouse model of lymphoma, researchers found that these cells can induce tumor regression by directly targeting ... Read more

April 12, 2019

Age, Obesity, Comorbidities Linked with Severe Fatigue Among Non-Hodgkin’s Lymphoma Survivors

News

While a significant proportion of non-Hodgkin’s lymphoma survivors suffer from severe fatigue, the type of initial treatment and Rituxan (rituxumab) use did not influence this outcome, a new study shows. Instead, ... Read more

April 5, 2019

Three-tiered Combination Stimulates Immune System to Attack Lymphoma Cells, Phase 1/2 Trial Shows

News

A combination of oral Imbruvica (ibrutinib), intratumoral CpG, and local low-dose radiation stimulates the immune system to safely and effectively attack lymphoma cells, according to a new study. The study, ... Read more

August 3, 2018

Gazyva Infusion Could Be Shorter for Some NHL Patients, Study Finds

News

Shortening the time needed for an infusion of Gazyva (obinutuzumab) did not affect the safety of Japanese patients with previously untreated CD20-positive B-cell non-Hodgkin’s lymphoma, a new study shows. “Safety, tolerability ... Read more

August 1, 2018

Ranimustine-based Conditioning Regimen Before Stem Cell Transplant Effective in DLBCL Patients, Study Suggests

News

A chemotherapeutic regimen that includes high-dose ranimustine may be used to prepare patients for a stem cell transplant, ultimately leading to high survival rates in patients with relapsed or high-risk ... Read more

June 29, 2018

New Biosensor Sheds Light on Behavior of Individual Cancer Cells, Study Reports

News

A newly developed biosensor that harnesses the power of nanophotonics is able to detect the secretion of cytokines — small inflammatory molecules that play important roles in cancer — from ... Read more

May 11, 2018

Bowel Rest Not Seen to Benefit NHL Patients with Gastrointestinal Involvement in Study

News

Bowel rest — in which patients do not ingest any food and are fed intravenously — does not significantly lower perforation rates or improve overall outcomes in non-Hodgkin’s lymphoma patients with ... Read more

April 20, 2018

Patients with Peripheral T-cell Lymphoma Resistant to First-Line Therapy Show Worse Outcomes, Study Finds

News

Patients with peripheral T-cell lymphomas receiving standard treatment have worse outcomes if they are not responsive to first-line therapy, a prospective study shows. Bone marrow transplants undertaken after these therapies have ... Read more